#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour Follicular lymphoma Rett syndrome Colon cancer Osteosarcoma recurrent Cardiomyopathy Macular telangiectasia Autoimmune demyelinating disease Bronchiolitis Drug eruption Extraskeletal ossification Neurodegenerative disorder Colitis ulcerative Pemphigus Central nervous system neoplasm More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Treatment Ehlers-Danlos syndrome – Life with Disease Piriformis syndrome – Trials in Disease Inclusion body myositis – Basic Information Hairy cell leukaemia recurrent – Diagnostics Glomerulonephritis rapidly progressive – Diagnostics Haemophilia B with anti factor IX Kearns-Sayre syndrome – Basic Information Ocular melanoma – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000034796 Anifrolumab SILYMARIN Warfarin Sodium Belzupacap Sarotalocan Digoxin Esomeprazole Magnesium Ephedrine Hydrochloride Pd01B Meropenem Anhydrous Mirabegron [11C]Az14193391 Alanine Donanemab Temsirolimus PICLIDENOSON Midodrine Hydrochloride Follitropin Delta ARFOLITIXORIN Adg126 More therapies…

    Learn about Your Condition

    Laryngeal cancer stage II Eye disorder Neonatal hyperglycaemia Angina pectoris Hypomagnesaemia Acute myocardial infarction Epicondylitis Procedural pain Endometrial adenocarcinoma Apheresis Decreased appetite Antisynthetase syndrome Noninfective chorioretinitis Tertiary adrenal insufficiency Alcohol abuse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Methotrexate Treatment for Patients with Erosive Hand Osteoarthritis Not Responding to Standard Therapy

    Recruiting

    2 1 1
    Investigated Drugs:
    • Folic Acid
    • Sodium Chloride Solution 0.9%
    • Methotrexate
    France

  • Study of Platelet-Rich Plasma Injections Combined with Exercise Compared to Betamethasone and Ropivacaine for Chronic Shoulder Pain Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone Acetate
    • Platelet Concentrate
    • Ropivacaine Hydrochloride
    Spain

  • Study of methadone and morphine combination for pain relief in patients with bone metastases from cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cancer pain
    Investigated Drugs:
    • Methadone Hydrochloride
    • Morphine Sulfate
    The Netherlands

  • Study of BNT326 alone and with BNT327 in patients with advanced solid tumors: Testing safety and effectiveness of new cancer treatments

    Recruiting

    1 1 1
    Investigated Drugs:
    • BNT327
    Belgium Germany Italy Spain

  • Study of MT-501 in patients with active Crohn’s Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Belgium Bulgaria Croatia Czechia Germany Italy +2

  • Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Mezigdomide
    • Dexamethasone
    • Elranatamab
    Germany Greece Norway Spain
Previous Page
1 … 117 118 119 120 121 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!